5 Best Large-Cap Biotech Stocks To Buy Now

3. Biogen, Inc. (NASDAQ:BIIB)

No of HFs: 59

Total Value of HF Holdings: $3.2 Billion

Biogen, Inc. is a multinational biotechnology company that focuses on the development, production, and marketing of therapies focusing on neurology, oncology, and immunology. During the third quarter of 2020, the company reported total revenue of $3,376 million.

Should value investors buy Biogen Stocks? In an article, we mentioned Distillate Capital’s investor letter and highlighted stocks including BIIB where he said:

“The biggest additions to the portfolio in the rebalance were Biogen and Philip Morris, each increasing around 30 basis points as their relative valuations improved over the quarter.”